Cytokinetics pharmaceuticals stock
WebApr 29, 2004 · Cytokinetics is registered under the ticker NASDAQ:CYTK . Their stock opened with $13.00 in its Apr 29, 2004 IPO. Cytokinetics is funded by 5 investors. Royalty Pharma and Deerfield are the most recent investors. Cytokinetics has invested in The Mended Hearts on Jan 30, 2024. This investment - Grant - The Mended Hearts - was … WebApr 10, 2024 · The company’s shares closed last Thursday at $78.78. Kumar covers the Healthcare sector, focusing on stocks such as Cytokinetics, Syndax Pharmaceuticals, and Fulcrum Therapeutics. According to...
Cytokinetics pharmaceuticals stock
Did you know?
WebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary ... WebCytokinetics Inc (CYTK) Stock Price Today, News, Quotes, FAQs and Fundamentals 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. CYTK Cytokinetics Inc 3,105 $33.36 $0.27 (0.80%) Today Sentiment 0.00% Message Vol. 42.11% Volume (M) 720,685.00 52-Wk High $55.80 52-Wk Low $33.37 About Feed …
WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Our Vision Leadership … WebNov 30, 2024 · PDUFA Target Action Date Set for November 30, 2024. FDA is Currently Not Planning to Hold an Advisory Committee Meeting to Discuss the Application SOUTH SAN FRANCISCO, Calif., Feb. 04, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) has …
WebJan 7, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. WebDec 20, 2024 · The CSPAs provide for the sale and issuance to the RTW Investors of 511,182 shares of Cytokinetics common stock of (the "Shares") with an aggregate purchase price of $20.0 million at a price per share of $39.125. The closing will occur on December 20, 2024.
WebNov 8, 2024 · Cytokinetics has granted the underwriters a 30-day option to purchase up to an additional $18.0 million aggregate principal amount of the notes in connection with the offering, solely to cover...
Web12 hours ago · In a report released yesterday, Madhu Kumar from Goldman Sachs maintained a Buy rating on Cytokinetics. The company’s shares closed last Thursday at … soilsmith services corvallisWebApr 11, 2024 · Discover historical prices for CYTK stock on Yahoo Finance. View daily, weekly or monthly format back to when Cytokinetics, Incorporated stock was issued. soils laboratory technician jobsWebApr 6, 2024 · CYTK Complete Cytokinetics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Cytokinetics Inc. Cytokinetics, Inc. is a biopharmaceutical company, which is … Ligand Pharmaceuticals stock price target raised to $155 from $135 at Benchmark … ACOR Complete Acorda Therapeutics Inc. stock news by MarketWatch. View real … Cytokinetics Inc. analyst estimates, including CYTK earnings per share … Cytokinetics Inc. Annual stock financials by MarketWatch. View the latest CYTK … Cytokinetics Inc. advanced stock charts by MarketWatch. View CYTK historial stock … słuchawki philips headphones 8000 seriesWebCytokinetics is led by a team of seasoned industry veterans with the shared objective to create the next great biopharmaceutical company that has the potential to change patients’ lives. With significant depth of industry experience and highly complementary skills in diverse fields including drug discovery, clinical research, business ... soils laboratoryWebDec 13, 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food & Drug Administration (FDA) Cardiovascular and Renal... soils in tropical rainforestWebMar 7, 2024 · Cytokinetics (Nasdaq:CYTK) earnings and revenue forecasts, price targets, future return on equity. ... President & Director exercised options and sold US$333k worth of stock Aug 04. Cytokinetics GAAP EPS of -$0.23 beats by $0.81, revenue of $88.97M beats by $85.24M ... High growth companies in the Pharmaceuticals & Biotech industry. soil smoothing tools crosswordWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. Investor Overview Stock … sluchawki playstation